CTPA has recently responded to news reports based around an abstract provided by the British Association of Dermatologists (BAD) about the preservatives methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI), ahead of a BAD conference that took place this week. As always, following any media reporting that could cause concern about the safety of cosmetic products, CTPA has a responsibility to reassure consumers that the matter is being handled responsibly, and as you would expect, CTPA also attended the conference where papers on MI and MCI were presented to listen to the concerns of the dermatologists first hand.
There has been an increase in the number of people who are attending dermatology clinics and reacting positively to MI in patch-testing. This is a complex issue and the cosmetics industry is committed to working in partnership with dermatologists, the broader scientific community and regulatory authorities to find out what this means for the population at large and how it can be most effectively managed in a timely manner.
Preservatives are essential in many consumer products, including cosmetics. Whatever action is taken it must be done with all the facts in front of us to ensure it is the most appropriate in the circumstances. It's also worth remembering that the labelling of cosmetic products allows people who know they're allergic to something to avoid that ingredient and product.